PKS Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
PKS Advisory Services's BMY Position: Q2 2026 in Review
PKS Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 10% in Q2 2026, buying an estimated $31.6K and bringing the position to 6,055 shares worth $349K. The position accounts for 0.06% of the portfolio, ranked #271.
PKS Advisory Services first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $349K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- PKS Advisory Services held 6,055 shares of Bristol-Myers Squibb worth $349K as of Q2 2026.
- PKS Advisory Services bought 551 Bristol-Myers Squibb shares in Q2 2026, an estimated $31.6K.
- Bristol-Myers Squibb made up 0.06% of PKS Advisory Services's portfolio in Q2 2026, its #271 holding.
- PKS Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- PKS Advisory Services's Bristol-Myers Squibb position peaked at $349K in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on PKS Advisory Services's 13F filing for Q2 2026, filed 4 Aug 2026.